To date, glioblastoma is not curable. Headed by Prof. Dr. Ghazaleh Tabababai, treatment of the first patient in an international Phase I clinical trial has started in Tübingen.  

Read the press release of University Hospital Tübingen (in German)

Copyright: Verena Müller / UKT